Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
1,555
-6,652
-81% -$779K 0.01% 195
2026
Q1
$994K Sell
8,207
-23
-0.3% -$2.65K 0.04% 107
2025
Q4
$873K Buy
8,230
+3,223
+64% +$303K 0.04% 122
2025
Q3
$424K Buy
+5,007
New +$412K 0.02% 148
2024
Q3
Sell
-1,871
Closed -$233K 221
2024
Q2
$233K Buy
+1,871
New +$241K 0.01% 164
2022
Q3
Sell
-2,356
Closed -$216K 137
2022
Q2
$216K Buy
+2,356
New +$209K 0.02% 134

Other funds holding MRK

GenTrust's MRK Position: Q2 2026 in Review

GenTrust reduced its Merck (MRK) stake by 81% in Q2 2026, selling an estimated $779K and leaving 1,555 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #195.

GenTrust first reported a position in MRK in Q2 2022 and has held it in 6 quarters since. The position peaked at $994K in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GenTrust held 1,555 shares of Merck worth $201K as of Q2 2026.
  • GenTrust sold 6,652 Merck shares in Q2 2026, an estimated $779K.
  • Merck made up 0.01% of GenTrust's portfolio in Q2 2026, its #195 holding.
  • GenTrust first reported a position in Merck in Q2 2022 and has held it in 6 quarters since.
  • GenTrust's Merck position peaked at $994K in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.